Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
PURPOSE: The aim of this study was to assess the prevalence of sarcopenia and depressive symptoms and estimate the association between them in elderly Chinese community-dwelling individuals. PATIENTS AND METHODS: A total of 948 elderly Chinese community-dwelling individuals were recruited through leaflets and posters from three communities in Chengdu, and 865 participants were analyzed in this cross-sectional study. Muscle mass was measured using the bioimpedance analysis, handgrip strength was measured with a handheld dynamometer, and physical performance was assessed via usual gait speed on a 6 m course. Sarcopenia was defined according to the recommended diagnostic algorithm of the Asia Working Group for Sarcopenia (AWGS). Depressive symptoms were assessed using the Chinese version of 15-item Geriatric Depression Scale (GDS-15) with a score of ≥5 indicative of the presence of depressive symptoms. RESULTS: A total of 865 participants were included in the analysis. The participants had a mean age of 68.68±6.46 years. Sixty-one (7.1%) participants and 71 (8.2%) participants were identified as having sarcopenia and depressive symptoms, respectively. After adjusting for age, sex, and other potential confounders, sarcopenia was found to be significantly associated with depressive symptoms (odds ratio [OR]: 2.23, 95% CI 1.06-4.92). CONCLUSION: The prevalence rates of sarcopenia and depressive symptoms were 7.1 and 8.2%, respectively, in elderly Chinese community-dwelling individuals, and sarcopenia was significantly associated with depressive symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152 · cited 1×
“The participants were categorized as follows: severe cognitive impairment (scores ranging from 0 to 17), mild cognitive impairment (MCI) (scores ranging from 18 to 23), and normal (scores ranging from 24 to 30).(15) In our study population, only 22 participants had scores #17 (six men and 16 women).”
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“Sarcopenia is a highly prevalent geriatric syndrome first described by Rosenberg in 1989 as the age-related loss of muscle mass and function.(5) In 2014, the Asian Working Group for Sarcopenia (AWGS) proposed a definition for sarcopenia and recommended approaches for the measurements of muscle mass, muscle strength, a…”
Fiske, A., Wetherell, J. L., & Gatz, M. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153621 · Cited by 2,353
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024
Cruz-Jentoft, A. J., Landi, F., Schneider, S. M., Zuniga, C., Arai, H., Boirie, Y., Chen, L.-K., Fielding, R. A., Martin, F. C., Michel, J.-P., et al. (2014) · Age and Ageing · doi:10.1093/ageing/afu115 · Cited by 1,963
Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · cited 1×
“32,33 Geda et al 34 followed a prospective cohort free of both depression and cognitive impairment and found that individuals who developed depression were more likely to subsequently develop MCI or dementia.”
The macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 1×
“The role of cytokines in depression was first proposed by Smith 23 in the form of the “macrophage theory of depression” and further studied by Maes et al 24 in the early 1990s.”
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (2011) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2011.03.003 · Cited by 786
Geda, Y. E., Knopman, D. S., Mrazek, D. A., Jicha, G. A., Smith, G. E., Negash, S., Boeve, B. F., Ivnik, R. J., Petersen, R. C., Pankratz, V. S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.435 · Cited by 230 · cited 1×
“32,33 Geda et al 34 followed a prospective cohort free of both depression and cognitive impairment and found that individuals who developed depression were more likely to subsequently develop MCI or dementia.”
Hamer, M., Batty, G. D., & Kivimaki, M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.124 · Cited by 121 · cited 1×
“9,20 In a recent cross-sectional survey, Wu et al 10 identified that both muscle mass and muscle strength were inversely associated with depressive symptoms in elderly Chinese individuals.”
The association between sarcopenic obesity and depressive symptoms in older Japanese adults
Ishii, S., Chang, C., Tanaka, T., Kuroda, A., Tsuji, T., Akishita, M., & Iijima, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162898 · Cited by 95 · cited 1×
“Additionally, sarcopenic obesity was demonstrated to be positively associated with depressive symptoms 21 and lower indicators of psychological health, 2).”
Cho, Y., Shin, S.-Y., & Shin, M.-J. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.04.002 · Cited by 75
Cited by
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
Fang, E. F., Xie, C., Schenkel, J. A., Wu, C., Long, Q., Cui, H., Aman, Y., Frank, J., Liao, J., Zou, H., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101174 · Cited by 675
Papadopoulou, S. K., Tsintavis, P., Potsaki, G., & Papandreou, D. (2020) · The Journal of nutrition, health and aging · doi:10.1007/s12603-019-1267-x · Cited by 321
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
Study on the comorbid mechanisms of sarcopenia and late-life depression
Wu, J., Tang, J., Huang, D., Wang, Y., Zhou, E., Ru, Q., Xu, G., Chen, L., & Wu, Y. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115538 · Cited by 12
“A growing body of literature has established that these two conditions not only frequently coexist, but also share underlying similarities and possible interrelations in their symptoms, pathophysiological mechanisms, and treatment approaches[69].”
Metadata
- Authors
- Wang, H., Hai, S., Liu, Y., Li, C., Liu, Y., Liu, P., Zhou, J., Yang, Y., & Dong, B.
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2018-09
- Volume
- Volume 13
- Pages
- 1605-1611
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W2891738166
- Cited by
- 67
- References
- 13
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.